DLB Stock Recent News
DLB LATEST HEADLINES
– Study demonstrated strong therapeutic responses across behavioral, functional, cognitive, and movement measures in patients with mild-to-moderate DLB –
Dolby Laboratories, Inc. (NYSE:DLB ) Q1 2025 Earnings Conference Call January 29, 2024 5:00 PM ET Company Participants Peter Goldmacher - VP, IR Kevin Yeaman - President, CEO & Director Robert Park - SVP & CFO Conference Call Participants Steven Frankel - Rosenblatt Securities Patrick Sholl - Barrington Research Ralph Schackart - William Blair Operator Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories Conference Call discussing First Quarter Fiscal Year 2025 results.
Dolby Laboratories (DLB) came out with quarterly earnings of $1.14 per share, beating the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $1.01 per share a year ago.
SAN FRANCISCO , Jan. 29, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the first quarter of fiscal 2025. "We are off to a strong start for FY25," said Kevin Yeaman, President and CEO, Dolby Laboratories.
DLB's fiscal first-quarter performance is likely to have gained from momentum across Dolby Atmos and Dolby Vision amid soft device sales.
Discretionary stocks like DLB, CCL, NFLX and AOUT are poised to benefit from the optimism surrounding rate cuts.
Dolby Laboratories (DLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Carnival Corporation, The Walt Disney, Dolby Laboratories, Royal Caribbean Cruises and Ralph Lauren are included in this Analyst Blog.
Discretionary stocks like CCL, DIS, DLB, RCL and RL are likely to benefit from slowing inflation.